Thrombomodulin Alfa Completed Phase 3 Trials for Idiopathic Pulmonary Fibrosis (IPF) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02739165Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis